- 8.1.2025
- News
Combat Cocktail: How America Overmedicates Veterans
A new Wall Street Journal report reveals the VA is prescribing risky drug combinations to hundreds of thousands of veterans with PTSD—despite known risks and internal warnings. The article underscores the urgent need for safer, more effective treatments like those VETS supports through research, advocacy, and access to psychedelic-assisted therapies.
- 7.25.2025
- News
Ibogaine: The Fight of a Lifetime
“Ibogaine: The Fight of a Lifetime” is a Fox Nation news segment highlighting the experiences of Special Operations veterans pursuing psychedelic-assisted therapy to address traumatic brain injury and PTSD.
- 7.23.2025
- News
Advocates want NC legislature to consider rules around psychedelics for PTSD treatment
Advocates in North Carolina are urging lawmakers to support Senate Bill 568, which would create a task force to explore safe, regulated access to psychedelic-assisted therapy for PTSD—especially for veterans. While not legalizing psychedelics, the bill aims to prepare the state for future FDA approval through infrastructure planning and veteran-focused care.
- 7.16.2025
- News
RFK Jr. and other Trump officials embrace psychedelics after FDA setback
RFK Jr. and former Trump officials are backing psychedelic therapies like MDMA and ibogaine, pushing for FDA approval amid growing bipartisan interest. The article highlights veteran voices, including VETS' Marcus Capone, advocating for access despite safety concerns.
- 7.2.2025
- News
Advocate reacts to Texas governor signing psychedelic research bill into law
An advocate featured by KXAN celebrates Texas’s new legislation as a turning point—allocating $50 million in public funding for ibogaine clinical trials to address PTSD, addiction, and brain injury. She highlights the significance of this support for veterans and first responders.